Sign in or register to see full information and data.

Studies / CAVD 504


Study information

Grant Affiliation:Haynes: B cell Lineage Envelope Design from RV144 Antibodies
Strategy:Combo: Protein & vector vaccines
Study Type:Antibody Screening
Stage:Assays Completed
Study Start Date:2015-08-28
Study Made Public:2016-07-20


CM244 neutralization activity of memory B cell culture supernatants and recombinant mAbs from an RV305 patient


CAVD 504 is an immunogenicity study to evaluate the neutralization activity of supernatants from memory B cell culture plates from a subject in RV305, the boost study to RV144.


ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/E

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.